市場調查報告書
商品編碼
1451229
2024-2032 年按產品類型(治療設備、診斷設備)、最終用戶(醫院和診所、睡眠實驗室、家庭護理機構等)和地區分類的睡眠呼吸中止設備市場報告Sleep Apnea Devices Market Report by Product Type (Therapeutic Devices, Diagnostic Devices), End-User (Hospitals and Clinics, Sleep Laboratories, Homecare Settings, and Others), and Region 2024-2032 |
2023 年,全球睡眠呼吸中止設備市場規模達到 80 億美元。展望未來, IMARC Group預計到 2032 年,市場規模將達到 138 億美元,2024-2032 年複合年成長率 (CAGR) 為 6%。
睡眠呼吸中止症或睡眠呼吸障礙 (SDB) 是一種急性疾病,患者在睡眠期間大腦的供氧受到阻礙。它是由氣道阻塞引起的,導致呼吸模式不規則和打鼾聲大,患者經常喘氣。睡眠呼吸中止症診斷和治療設備,例如持續性正壓呼吸器(CPAP)、雙水平氣道正壓通氣(BiPAP) 和可變氣道正壓通氣(VPAP) 機,用於評估患者在睡眠期間的呼吸和其他身體功能。除此之外,許多口腔裝置,包括下顎前移裝置(MAD)和舌頭固定裝置,也用於治療輕度至中度睡眠呼吸中止症病例。
阻塞性睡眠呼吸中止症(OSA)、中樞性睡眠呼吸中止症和複雜睡眠呼吸中止症候群的盛行率不斷增加,是推動市場成長的關鍵因素之一。此類疾病在老年人群和患有糖尿病、高血壓和心血管疾病 (CVD) 等其他疾病的個體中非常普遍,這促進了產品在已開發國家和新興國家的採用。此外,產品創新,包括檢查睡眠模式、心血管、血氧測定和呼吸參數以診斷 OSA 的中心外 (OOC) 測試設備,也是另一個主要的成長誘導因素。其他因素,包括醫療保健基礎設施的改善、人們對睡眠呼吸中止長期影響的認知不斷提高,以及各種品牌的小型化和推出價格實惠的設備,預計將進一步推動市場發展。
阻塞性睡眠呼吸中止症(OSA)、中樞性睡眠呼吸中止症和複雜睡眠呼吸中止症候群的盛行率不斷增加,是推動市場成長的關鍵因素之一。此類疾病在老年人群和患有糖尿病、高血壓和心血管疾病 (CVD) 等其他疾病的個體中非常普遍,這促進了產品在已開發國家和新興國家的採用。此外,產品創新,包括檢查睡眠模式、心血管、血氧測定和呼吸參數以診斷 OSA 的中心外 (OOC) 測試設備,也是另一個主要的成長誘導因素。其他因素,包括醫療保健基礎設施的改善、人們對睡眠呼吸中止長期影響的認知不斷提高,以及各種品牌的小型化和推出價格實惠的設備,預計將進一步推動市場發展。
The global sleep apnea devices market size reached US$ 8.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.8 Billion by 2032, exhibiting a growth rate (CAGR) of 6% during 2024-2032.
Sleep apnea, or sleep-disordered breathing (SDB), is an acute medical condition in which oxygen supply to the brain is obstructed during sleep. It is caused by blockages in the airway resulting in irregular breathing patterns and loud snoring, with the individual often gasping for breath. Sleep apnea diagnostic and therapeutic devices, such as Continuous Positive Airway Pressure (CPAP), Bilevel Positive Airway Pressure (BiPAP) and Variable Positive Airway Pressure (VPAP) machines, are used to evaluate the patient's respiratory and other bodily functions during sleep. Apart from this, numerous oral devices, including the Mandibular Advancement Device (MAD) and tongue retaining device, are also utilized to treat mild to moderate cases of sleep apnea.
The increasing prevalence of obstructive sleep apnea disorder (OSA), central sleep apnea and complex sleep apnea syndrome, are among the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, product innovations, including Out-of-Center (OOC) testing devices that examine sleep patterns, cardiovascular, oximetry and respiratory parameters for the diagnosis of OSA is also acting as another major growth-inducing factor. Other factors, including improving healthcare infrastructure and growing awareness regarding the prolonged effects of sleep apnea, along with the miniaturization and launch of affordable devices by various brands, are projected to drive the market further.
The increasing prevalence of obstructive sleep apnea disorder (OSA), central sleep apnea and complex sleep apnea syndrome, are among the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, product innovations, including Out-of-Center (OOC) testing devices that examine sleep patterns, cardiovascular, oximetry and respiratory parameters for the diagnosis of OSA is also acting as another major growth-inducing factor. Other factors, including improving healthcare infrastructure and growing awareness regarding the prolonged effects of sleep apnea, along with the miniaturization and launch of affordable devices by various brands, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global sleep apnea devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type and end-user.
Therapeutic Devices
Positive Airway Pressure (PAP) Devices
Oral Devices
Nasal Devices
Chin Straps
Others
Diagnostic Devices
Actigraphs
Polysomnography Devices
Sleep Screening Devices
Others
Hospitals and Clinics
Sleep Laboratories
Homecare Settings
Others
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Others
Middle East and Africa
Turkey
Saudi Arabia
Iran
United Arab Emirates
Others
The competitive landscape of the industry has also been examined with some of the key players being BMC Medical Co., Braebon Medical Corporation, Cadwell Laboratories, CareFusion Corp., Curative Medical, Devilbiss Healthcare, Fisher & Paykel Healthcare, GE Healthcare, Invacare, Oventus Medical, Panthera Dental, ResMed, Somnomed Ltd., Vyaire Medical Inc., Whole You Inc., etc.